financetom
Business
financetom
/
Business
/
Danaher Fiscal Q1 Adjusted Earnings, Sales Down
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Danaher Fiscal Q1 Adjusted Earnings, Sales Down
Apr 23, 2024 4:09 AM

06:55 AM EDT, 04/23/2024 (MT Newswires) -- Danaher ( DHR ) reported fiscal Q1 adjusted earnings of $1.92 per diluted share, down from $2.05 a year earlier.

Analysts polled by Capital IQ expected $1.71.

Sales for the quarter ended March 29 were $5.8 billion, down from $5.95 billion a year earlier.

Analysts surveyed by Capital IQ expected $5.62 billion.

The company expects Q2 non-GAAP core revenue to be down mid-single digits and down low-single digits for the full year 2024.

Danaher ( DHR ) shares rose more than 8% in premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: French Regulators Nearing Antitrust Charges Against Nvidia
Update: Market Chatter: French Regulators Nearing Antitrust Charges Against Nvidia
Jul 15, 2024
01:48 PM EDT, 07/15/2024 (MT Newswires) -- (Adds Nvidia declining comment on reported investigation). Nvidia ( NVDA ) is being investigated by French antitrust regulators who are close to charging the chipmaker with anti-competitive practices, Reuters reported on Monday, citing the president of France's Autorite de la Concurrence. Agency president Benoit Coeure told the news service on the sidelines of...
Medical Technology Companies Poised for Another 'Solid' Quarter, Morgan Stanley Says
Medical Technology Companies Poised for Another 'Solid' Quarter, Morgan Stanley Says
Jul 15, 2024
01:52 PM EDT, 07/15/2024 (MT Newswires) -- Most medical technology companies appear well positioned as they prepare to report their Q2 financial results, analysts at Morgan Stanley said Monday, citing recent discussions with the companies and channel checks with customers. Overall, industry fundamentals are solid, with utilization rates and volumes running well across most end-markets for medtech companies, Morgan Stanley...
Vertex sues US over fertility support program for Casgevy gene editing therapy
Vertex sues US over fertility support program for Casgevy gene editing therapy
Jul 15, 2024
July 15 (Reuters) - Vertex Pharmaceuticals ( VRTX ) sued the U.S. Department of Health and Human Services on Monday, seeking a court declaration that a fertility support program for patients who are prescribed its gene editing therapy Casgevy does not violate federal anti-kickback laws. Casgevy is approved for the treatment of two genetic disorders - sickle cell disease and...
Uber's Competing Taxi Operators Win Appeal to Slash Tax in UK
Uber's Competing Taxi Operators Win Appeal to Slash Tax in UK
Jul 15, 2024
01:58 PM EDT, 07/15/2024 (MT Newswires) -- Uber's ( UBER ) competing taxi operators won an appeal Monday to slash a 20% tax charge on rides outside of London. The UK Court of Appeal overturned a decision by London's High Court in 2023 that imposed a 20% value added tax on private-hire operators after Uber ( UBER ) filed a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved